NEXARALABSUSA
CJC-1295 (DAC) 5mg research peptide vial — Nexara Labs USA
Click to enlarge

CJC-1295 (DAC)

CJC-1295

$99.00· 10mg
≥99%

CJC-1295 with Drug Affinity Complex (DAC) is a synthetic analog of growth hormone-releasing hormone (GHRH) studied in laboratory research for its extended receptor interaction profile. The DAC modification enables prolonged binding activity, making it a subject of interest in research investigating sustained peptide-receptor signaling dynamics. Experimental studies explore CJC-1295 (DAC) in the context of GHRH receptor activation kinetics, peptide half-life extension mechanisms, and downstream signaling pathway analysis. These investigations contribute to broader research on modified peptide analogs and their behavior in controlled experimental systems. CJC-1295 (DAC) continues to be examined in laboratory models focused on growth hormone-releasing hormone receptor biology and extended-duration peptide signaling. For research use only. Not for human consumption.

CJC-1295 (DAC)$99.00

Certificates of Analysis (COAs) are available upon request. Contact nate@nexaralabsusa.com for COA documentation.

For research use only. Not for human consumption.

Molecular Profile

Purity
≥99%
Research Applications
  • GHRH receptor signaling research
  • Peptide half-life extension studies
  • Sustained-release analog investigations
  • Endocrine pathway modeling
What's Included
  • 1x lyophilized vial (10mg)
  • Certificate of Analysis (upon request)
  • Storage instructions
Testing & Verification
  • HPLC
  • Mass Spectrometry
  • LAL Endotoxin
  • Sterility

For research use only. Not for human consumption.

These products are not intended to diagnose, treat, cure, or prevent any disease. They are sold strictly as research chemicals for laboratory use.

Preorder: All orders are currently preorders. Expected fulfillment within 6 weeks. You will receive tracking information once your order ships.